On the Influence of Cyclization on Molecular Rotation

Tomsk.
Submitted 1929 | SovietRxiv: ru-192901.07849 | Translated from Russian

Abstract Generated abstract

This paper examines how cyclization affects molecular optical rotation and evaluates the question through the author’s theory of meso-structure in organic compounds. Using about 135 comparisons drawn from an index of optically active substances, it introduces a coefficient of cyclization to compare rotation changes between cyclic and corresponding non-cyclic compounds, then reinterprets the cases by distinguishing ordinary cycles from proposed mesocycles. Although the raw comparisons show both increases and decreases in nearly equal numbers, the author argues that, when mesocyclization is included, increased cyclicity usually corresponds to increased molecular rotation, with notable exceptions among camphoric acid derivatives, aromatic tartaric acid derivatives, and some phenylsuccinic acids. A broader tabulation of mono- and diascarate substances is used to support the suggestion that non-cyclic optically active compounds tend to have lower molecular rotations than cyclic or mesocyclic ones.

Full Text

I. I. Kotyukov

On the Influence

of Cyclization

on

Molecular

Rotation

Tomsk.
1929.

I. I. Kotyukov.

On the Influence of Cyclization on Molecular Rotation.

(The theory of the meso-structure of organic compounds IV).

The problem of the dependence of the magnitude of the angle of rotation of the plane of polarization on structure is one of the most enigmatic and complex areas of physical chemistry. Despite the enormous number of works on this question, despite the existence of entire schools occupied solely with it, we still do not have here a single firm regularity. The constant of molecular rotation is the most capricious and whimsical characteristic of a system. The slightest change in structure, temperature, concentration, very sharply, sometimes by a jump, changes the magnitude of the angle of rotation. The constant is influenced in the most unexpected way by the solvent, the slightest impurities, the wavelength of light, and even the time elapsed since the preparation of the system. As for the principal factor—structure—then with the simplest lengthening of a chain (e.g. ethyl—propyl) the constant often changes by a very considerable angle. At present we are completely unable to predict how the constant will change depending on the position of a substituent in the nucleus, depending on the introduction of a double or triple bond; we cannot sum the influences of several asymmetric atoms in a molecule, the influences of several radicals, etc.

The sharpest and crudest change in structure is an increase in the cyclicity of the molecule. It has long been known that cyclization very sharply affects the rotation constant, often changing it severalfold in the vast majority of cases in the direction of increase. However, here too not a few exceptions have been observed, which was especially well studied for camphoric acid and its derivatives.

The theory of the meso-structure of organic compounds*) proposes structures that differ very sharply from the classical ones precisely in their cyclicity. Since in the meso-formula there are bonds obtained as a result of the saturation of the mesovalence of hydrogen by the residue of an atom possessing affinity for it and located in the same molecule, this naturally leads to the formation of a new “mesocycle” in the molecule. All meso-formulas are much more cyclic than the corresponding classical ones. It is therefore natural that, for the physicochemical proof of the new structures, we pay all our attention to properties that are in acute dependence on cyclization. The constant of molecular rotation proves in this respect to be very rewarding material.

The question of the influence of cyclization on rotation as such has actually been raised comparatively rarely, and therefore the material here is extremely scattered. We were able to collect it completely only thanks to our “Index of Optically Active Substances.” In selecting the material we paid attention only to the simplest possible cases of cyclization—with ex-

) Izvestiya S. T. I. T.* 48 (1927); Chem. Centr. 1928.
Chem. Abst. 1928.

falling, where possible, on a simple substance, in most cases \(H_2O\), \(NH_3\), and rarely \(C_6H_5NH_2\). Unfortunately, the two substances were not always tested for rotation in one and the same solvent, partly because of insolubility, partly because cyclization was not the aim of the investigation. In some cases the two substances were taken from different authors, whose works are separated by a considerable interval of time. In all, about 135 comparisons were obtained, and it turned out that both the magnitude and the direction of the rotation upon cyclization change in the most varied manner. For convenience in comparing the magnitude of the effect, we calculated, for all cases, the relative change, which we called the coefficient of cyclization. It is calculated by the formula

\[ K = \frac{M - m}{m}, \]

where \(M\) is the larger constant and \(m\) the smaller one, so that, when the rotation increases, the calculation was made with respect to the non-cyclic substance, and when it decreases, with respect to the cyclic one. The coefficient is considered positive if the rotation increases, and negative if it decreases.

Tables A.I; A.II; B.I; B.II.

As is seen from the tables, cyclization exerts a most unexpected influence, and almost always a very strong one. Decrease and increase are observed in almost equal numbers of cases—59 and 75.

However, the picture changes sharply if we construct mesoformulas for all cases and take into account the degree of both proto- and mesocyclization. With this method of comparison it turns out that cyclization almost always increases the constant. Let us consider the material by individual groups of substances.

Mono- and dibasic polyoxy acids (A.I Nos. 3, 20, 22, 29, 32, 35, 36, 37, 41; A.II Nos. 6, 26, 27; B.I Nos. 4, 15, 42) almost all increase the rotation upon cyclization. No. 15.B.I was taken from different authors (1924 and 1911). In No. 42 the salt is taken into account for the acid. Thus the only exception is B.I.4—rhodeohexonic acid. If the carboxyl in these acids has oxygen with a residue, then it has no hydrogen, for, owing to the lightness of the OH group, all hydrogens sit firmly. Thus the mesoformula of these acids does not differ from the protoformula, and here cyclization always increases the rotation.

The next large group consists of derivatives of camphoric acid.

(A.I.4, 21; A.II.1, 2, 11, 14; B.I.2, 6, 9, 12, 13, 16, 18, 19, 20, 21, 26, 27, 29, 30, 31, 32, 33, 34, 36, 37, 38, 39, 41, 43, 45, 48; B.II.1, 3, 6, 9, 10). In the enormous majority of cases the rotation here falls. However, the mesoformula of camphoric acid is more cyclic than that of its anhydride, so that, according to mesotheory, here there is a decrease in cyclicity:

[structural formulas]

Camphoric acid (three cycles).

\[ \begin{array}{c} \text{CH}_3 \qquad\qquad \text{CO}\\ \diagdown \qquad\quad \diagup \qquad\quad \diagdown\\ \text{C} \qquad\qquad\qquad \text{O}\\ \diagup \qquad\qquad\qquad\diagup\\ \text{CH}_2 \qquad\qquad \text{C}\!\cdot\!(\text{CH}_3)_2\\ \diagdown \qquad\quad \diagup\\ \text{CH}_2\!-\!\text{CH}\!-\!\text{CO} \end{array} \]

Its anhydride (two rings).

As is clear from the formulae, camphoric acid has three rings, whereas the anhydride has only two. The meso-formula is strongly supported by the circumstance that dehydrocamphoric acid

\[ \begin{array}{cc} \begin{array}{c} \text{CH}{=}\text{C}\!\cdot\!\text{COOH}\\ \phantom{\text{CH}{=}}\vert\\ \phantom{\text{CH}{=}}\text{C}\!\cdot\!(\text{CH}_3)_2\\ \phantom{\text{CH}{=}}\vert\\ \text{CH}_2-\text{C}\!\cdot\!\text{COOH} \end{array} & \begin{array}{c} \text{H}\qquad\qquad\qquad\text{H}\\ \diagup\ \diagdown \qquad\qquad \diagup\ \diagdown\\ \text{O}\qquad \text{CH}\!-\!\text{C}\qquad\qquad \text{O}\\ \Vert\qquad \diagdown\qquad \vert\qquad\quad \diagup\!\!\Vert\\ \text{C}\!-\!\text{C}\qquad\text{C}\!-\!\text{C}\\ \vert\qquad \vert\qquad \diagdown\qquad \vert\\ \text{OH}\quad \text{CH}_3\qquad \text{C}\qquad \text{OH}\\ \qquad\qquad\qquad (\text{CH}_3)_2 \end{array} \end{array} \]

does not give an anhydride, which, in comparison with the easy anhydrization of camphoric acid, cannot but appear very strange. The impossibility of obtaining an anhydride here is explained by the fact that, according to the meso-theory, the H at the double bond possesses very strong meso-valency. It binds the carbonyl oxygen so firmly that the possibility of removing water disappears entirely because of the steric remoteness of the hydroxyl groups. According to this scheme the meso-formulae of the other derivatives will also be constructed, so that the substances of category A will be exceptions to the general rule of an increase in the angle with increasing cyclicity. As for the substances A.I.4; A.II.2 and 14, i.e. O-chloro- and bromophenyl-substituted compounds, they are, in general, unusually capricious in their rotation: they change both magnitude and sign depending on the solvent, so that they cannot be regarded as typical. This is an accidental exception which, upon special closer investigation, may also fit into the system.

A very interesting deviation is found in α-naphthyl-α-campheramic acid (A.I.21), especially if it is compared with the corresponding β-derivative (B.I.39), which on cyclization behaves normally from the point of view of the meso-theory.

We are trying to discover the cause of these exceptions experimentally.

Very remarkable is the identical rotation of α-hydrindone β-benzoyl-O-carbonic acid (A.II.3) and of the corresponding spiran. From the point of view of the meso-theory the cyclicity here is the same in both:

\[ \begin{array}{c} \text{CH}_2 \qquad\qquad \text{CH}_2\\ \diagup \qquad \diagdown \qquad \diagup \qquad \diagdown\\ \text{C}_6\text{H}_4 \qquad \text{C} \qquad \text{C}_6\text{H}_4\\ \diagdown \qquad \diagup\ \diagdown \qquad \diagup\\ \text{C}\!-\!\text{O}\cdots\text{H} \qquad\quad \\ \vert \qquad\qquad\qquad \diagdown\\ \text{OH}\qquad\qquad\quad \text{CO} \end{array} \]

Acid

\[ \begin{array}{ccccccccc} && \mathrm{CH_2} &&& \mathrm{CH_2} \\ & / && \backslash && / && \backslash \\ \mathrm{C_6H_4} &&& \mathrm{C} &&&& \mathrm{C_6H_4} \\ & \backslash && / && \backslash && / \\ & \mathrm{C} {-} \mathrm{O} &&&& \mathrm{CO} \\ & | \\ & \mathrm{O} \end{array} \]

Spiran.

Derivatives of tartaric acid are divided into two categories: those substituted in the hydroxyl increase rotation (A.I.1, 23, 30, 42; A.II.8, 10, 20), while those substituted in the carboxyl lower it (B.I.1, 3, 5, 7, 23—25). The latter include exclusively aromatic amides, and cyclization here proceeds with the loss either of aniline or of its substituent. Since the diamide of tartaric acid possesses, in comparison with the acid itself, a very high activity, its meso-formula will be

\[ \begin{array}{c} \mathrm{C} \\ \mathrm{O} \\ \diagdown \quad \diagup \\ \mathrm{OH.CH} \qquad \mathrm{NH_2} \\ \mathrm{OH.CH} \qquad \mathrm{NH_2} \\ \diagup \quad \diagdown \\ \mathrm{C} \\ \mathrm{O} \end{array} \]

Then there will be no difference in cyclicity between its substituted derivative and the corresponding imide, and the fall in activity is explained only by the loss of the heavy aromatic radical.

In some cases a high value of rotation is undoubtedly motivated by association, for example (B.I.8) in propylene glycol and in the substance (B.II.7). The remaining examples can be brought under one or another of the schemes considered above, and especially under camphoric acid. Individual cases sometimes do not yield to explanation and plainly contradict the meso-theory. Thus, for example, mono- and diphenylantaric acids, upon cyclization to anhydrides, decrease their activity, whereas cyclicity increases. It is possible that we do not perceive what is at issue here.

On the basis of the foregoing, the difference in the angle of rotation in optically active stereoisomers becomes comprehensible—a fact entirely inexplicable for the classical theory.

Furthermore, it is clear that increasing the unsaturation of a molecule leads to an increase in rotation only by virtue of the appearance of mesovalency in the H atom adjacent to the double bond and of the subsequent cyclization. This is why a triple bond, near which there is no hydrogen, does not increase rotation.

Thus, an analysis of all known cases of cyclization from the standpoint of the theory of meso-structure leads us to the inevitable conclusion that rotation is increased in the enormous majority of cases. Exceptions to this rule are isolated, and it is possible that, upon special investigation, they may be incorporated into the system. Every time that we

we have an unexpected jump in the magnitude of rotation, it follows that mesocyclization should be sought, which in the present respect is entirely equivalent to cyclization through the principal valences. It is possible that the magnitude of this influence depends on the strength of the bonds in the cycle and, for meso-bonds, will be weaker than for the principal-valence bonds.

If cyclization, irrespective of whether it occurred through mesovalence or through a principal valence, invariably increases rotation, then in such a case we are entitled to expect, among substances containing an asymmetric carbon atom not situated in a cycle, a certain minimum of rotation. In other words, if one constructs meso-formulas for all known optically active substances and arranges them according to the number of cycles, whether mesocycles or protocycles, they should also be arranged approximately according to the magnitude of molecular rotation. Non-cyclic substances will have the smallest rotation, and among strongly rotating ones there will be none of them. This proposition has in fact been borne out. Here, however, we must make a number of reservations. At present about 12,000 optically active substances are known. The “construction” of meso-formulas is based not on any firm experimental foundations, but on logical considerations of a theoretical character—considerations whose starting points will probably change when the appropriate experimental material becomes available. Therefore we considered it rational to make, so to speak, a “rough sketch” of these formulas for the time being, without giving them any final form. How precisely this is done systematically we indicate at the end of the article. Moreover, the figures available in the literature are far from always reliable, owing to the slight certainty as to the optical purity of the system.

Nevertheless, a fairly definite result is obtained. For simplicity of accounting we selected only substances containing one or two identical asymmetric carbon atoms. It is convenient to call the latter by the apharetic term ascarat. Thus we are dealing with mono- and diascarate substances. Of the former, 2400 have been prepared, and of the latter, 500. From both groups we selected only non-cyclic and monocyclic ones.

The more complex substances were not considered. We divided the mono-ascarates into three categories:

  1. ascarat not a member of a cycle (“amesic” substances), 510 items.
  2. ascarat a member of one mesocycle (monomesocyclic), 176 items, and
  3. ascarat a member of one protocycle (monoprotocyclic), 80 items.

The diascarates are divided into the same categories—59, 18, and 13 respectively.

According to the magnitude of molecular rotation, the named categories are distributed as follows:

Table.

Angle Monosaccharates—Amesic: no. of subst. Monosaccharates—Amesic: % Monosaccharates—Mesocyclic: no. of subst. Monosaccharates—Mesocyclic: % Monosaccharates—Protocyclic: no. of subst. Monosaccharates—Protocyclic: % Disaccharates—Amesic: no. of subst. Disaccharates—Amesic: no. per 1 ascar. Disaccharates—Amesic: % Disaccharates—Mesocyclic: no. of subst. Disaccharates—Mesocyclic: no. per 1 ascar. Disaccharates—Mesocyclic: % Disaccharates—Protocyclic: no. of subst. Disaccharates—Protocyclic: no. per 1 ascar. Disaccharates—Protocyclic: %
0—5 58 11,37 6 3,4 9 11,2 3 14 23,7 — — — 2 2 15,3
—10 106 20,78 9 5,11 7 8,7 11 8 13,5 — 1 5,5 — — —
15 97 19,01 16 9,09 4 5,0 8 5 8,47 — 2 11,1 — 1 7,6
20 48 9,41 11 6,25 2 2,5 4 12 20,3 — 1 — — — —
25 72 14,11 11 6,25 6 7,5 1 3 5,08 — — — — 1 7,6
30 30 5,88 9 5,11 5 6,2 1 3 5,08 — — — 1 — —
35 33 6,47 12 6,81 4 5,0 4 1 1,7 2 2 11,1 — — —
40 10 1,96 2 1,1 4 5,0 5 — — — 1 5,5 — — —
45 7 1,3 6 3,4 4 5,0 4 — — — 1 5,5 1 — —
50 6 1,17 8 4,54 5 6,2 1 1 1,7 — — — — 1 7,6
55 7 1,37 10 5,68 2 2,5 3 — — — 1 5,5 — — —
60 1 — 8 4,54 — — — 1 1,7 — — — — — —
65 4 0,78 12 6,81 3 3,7 1 3 5,08 — — — — — —
70 2 0,39 9 5,11 — — — — — 2 — — — 1 7,6
75 8 1,56 11 6,25 2 2,5 — 1 1,7 1 — — — 1 7,6
80 — — 6 3,4 2 2,5 — — — — — — — — —
85 4 0,78 2 1,1 2 2,5 — 2 3,8 1 — — — — —
90 — — 4 2,27 1 1,2 — — — — 1 5,5 — — —
95 1 — 2 1,1 2 2,5 1 — — — 2 11,1 — — —
100 2 0,39 3 1,7 — — — — — — — — 1 — —
105 5 0,98 2 1,1 — — — — — 1 — — — 1 7,6
110 4 0,78 1 0,56 3 3,7 — — — — — — — — —
115 3 0,58 5 2,84 — — — 1 1,7 — — — — — —
120 — — 4 2,27 — — 1 — — — — — — — —
125 3 0,58 — — 4 5,0 — 1 1,7 — — — 1 — —
130 1 — 1 — — — 3 — — — 1 5,5 — — —
135 — — 1 — 3 3,7 — — — — 1 5,5 — 1 7,6
140 1 — — — — — — — — — 2 11,1 1 — —
145 — — 1 — — — — 1 1,7 — 1 5,5 — 1 7,6
150 — — 1 — 4 5,0 1 — — — 1 5,5 — — —
155 — — — — — — — — — — 2 11,1 — — —
160 — — 1 — — — — — — 1 — — — — —
165 — — — — 1 1,25 — — — — — — — — —
170 — — 1 — — — — — — 1 — — — — —
175 — — — — — — 2 — — — — — — — —
above 1 — 1 — 1 — 3 — — 8 — — 6 3 23,0

The data of the table have been reduced to the appended graph, with the angles plotted on the abscissa and, on the ordinate, the number of substances rotating by the corresponding angle.

As is evident from the table and the graph, all amesic substances possess a very small angle of rotation—namely \(0\)—\(35^\circ\), with the overwhelming majority of them (\(65\%\)) at \(5\)—\(25^\circ\). The relations are especially sharp in the case of dicarboxylic substances. As for the meso- and protocyclic substances, they are distributed rather uniformly over the graph from \(0\)—\(130^\circ\).

We hope that the calculation proposed here is the first real approach to the construction of a theory embracing the entire mass of prepared optically active compounds. There are very few sharp exceptions here; in fact they are isolated, and special investigation will explain in detail the cause of their deviation.

With this article we conclude the exposition of the dogmatic part of the theory of meso-structure. We regard it as an enormous, all-embracing working hypothesis. The experimental future will show how far all that has been set forth above is valid, and how far it may be extended to fields not touched upon here.

Especially interesting in this respect appear to be the cis-trans isomerism of naphthenes and the magnitude of the constant of electrolytic dissociation.

As the principal conclusion from all the preceding material we put forward the following proposition: the force of the mesovalency of hydrogen is a function of the intensity of exchange by means of neighboring carbon atoms. This dependence appears because carbon gives to carbon one bond more than a quarter of its entire affinity. From this point of view, all radicals of organic chemistry are divided into two groups: mesophoric, possessing a residual means, and amesic—residues not possessing it.

Residues occur at H, O, N, Cl. Residues at H are borne by groupings with tertiary H, with H directed toward the nucleus, with secondary H adjacent to a negative group, an oxime group, and possibly an aldehyde group. Residues at O are borne by the carbonyl of carboxyl, the isonitroso group, the nitro group, hydroxyl adjacent to a negative group, and carbonyl adjacent to such a group. Nitrogen and the haloids are evidently always mesophoric. It is possible that in the carboxyl group the mesophore is hydroxyl, and not carbonyl.

Amesic groups have no residues. These are negatively directed H; the same H at secondary and tertiary C with a positive nearest group (\(\mathrm{OH}\), \(\mathrm{NH_2}\), etc.); hydroxyl and carbonyl at C with a positive group; and, finally, fatty saturated radicals.

The fundamental assumption is the occurrence of a bond between the residue—chiefly H—and the atom having affinity for it. If this takes place in one molecule, it causes the formation of a new ring, in the overwhelming majority of cases five- or six-membered. If this takes place between different molecules, it leads to the formation of a molecular compound.

A formula with the designation of such bonds, called a “mesoformula,” is constructed as follows. First it is necessary to establish, in final form, the protoformula, i.e. the distribution of the principal valencies. Then the distribution formula is established, i.e. the protovalencies are differentiated. They are subdivided into three approximate groups: strong, ordinary, and weak. Their strength is established on the basis of the usual theories of exchange by means: the theory of negative groups, the theory of unsaturation, the theory of directedness, etc.

After the establishment of the carbon bonds, the affinity between C and H is distributed, making use of the “basic proposition” cited above. Finally, meso-bonds are closed between the residues obtained; among several possibilities, those most probable according to the affinity of the residues are chosen. Here the number of possible “mesoisomers” is established. The mesoformula obtained in this way, i.e. by pure reasoning, is confirmed experimentally, if, of course, the corresponding material is not available in the literature. The experimental proof is carried out as follows.

If we need to prove the presence of a meso-bond between any two radicals \(R_1\) and \(R_2\) in a molecule, then we must prepare an optically active substance of the formula

\[ \begin{array}{ccccc} & R_1 & & R_2 & \\ & \diagdown & & \diagup & \\ & & C & & \\ & \diagup & & \diagdown & \\ CH_3 & & & & C_2H_5 \end{array} \]

If the angle of rotation is less than \(25^\circ\), then the substance is “amesic,” and there is no meso-bond. The presence of an H residue in some radical is proved by the occurrence of “mesoisomerism” and by the number of mesoisomers. It is necessary to prepare the oxime

\[ \begin{array}{ccc} C_6H_5.C & - & R \\ \| & & \\ \mathrm{HO}\;N & & \end{array} \]

If there are two isomers here, then \(R\) will contain an H-residue. The same applies to the residue at oxygen. For final confirmation, substances of the same structures are now prepared, but the residue suspected to be H is replaced by “amesic” \(CH_3\). Then the angle of rotation must fall, and the mesoisomerism must also disappear. From a comparison of all the material, the final mesoformula is then constructed.

In many cases, optically active substances and the corresponding oximes can be found in the literature, and the mesoformula can be constructed, so to speak, by reasoning alone. However, this cannot of course be carried out systematically; and therefore there is here an enormous field for experimentation.

The proposed theory creates an especially keen interest in the optical activity and isomerism of oximes.

The present work arose and was, in principle, carried out within the walls of the laboratory of colloid chemistry at the Voronezh Agricultural Institute, under the direction of A. V. Dumanskii. It could come to light only thanks to the utterly exceptional cultural environment created in the laboratory by the exalted personality of Anton Vladimirovich. An extraordinary scientific “tolerance,” extreme delicacy and caution in dealing with another “scientific soul,” the immediate granting of the fullest “freedom of research” in the presence of “one’s own” ideas, all-round support, assistance, and unfailing sympathy—this is what accompanied me throughout my stay in the laboratory and made it possible to develop the mesotheory. I offer to the deeply respected and dear Anton Vladimirovich my greatest gratitude for his rare participation and attention shown to my work.

The theory of mesostructure in manuscript was reviewed by Academician N. D. Zelinsky. There is no doubt that, had it not been for Nikolai Dmitrievich’s authoritative support, the work would not have seen the light of day. Nikolai Dmitrievich pointed out to me a large number of errors in the work, many of which, incidentally, owing to my lesser competence and in part to haste, I still was unable to correct. Yet the positive things that I heard from so great an authority gave me the necessary confidence that there is a grain of truth in my work. I take this opportunity to express here to the deeply respected and most highly esteemed Nikolai Dmitrievich my profound gratitude.

Tomsk, October 15, 1928.

A. Coefficient of elongation. I. The sign does not change.

No. Series No. Formula Molecular wt. Name. Protoformula Solvent \([M]^{20}_{D}\) Splitting off Cyclization coefficient Citation
1 83 \(C_{12}H_{15}O_{4}N\) 269 \(p\)-ethoxyphenyl—tartranic acid, \(C_{2}H_{5}O \cdot C_{6}H_{4} \cdot NH \cdot CO \cdot CH(OH)_{2} \cdot COOH\) \(H_{2}O\) 287.8 18.II.274
1 83 \(C_{12}H_{13}O_{3}N\) 251 \(p\)-ethoxyphenyl—tartrimide \(CH_{3}OH\) 290.4 \(H_{2}O\) 0.009 18.II.274
2 55 \(C_{16}H_{20}N_{2}O_{3}\) 312 Dibenzylamide of malic acid, \(C_{6}H_{5} \cdot CH_{2} \cdot NH \cdot CO \cdot CHOH \cdot CH_{2} \cdot CO \cdot NH \cdot CH_{2} \cdot C_{6}H_{5}\) \(CH_{3}OH\) 115.12 04.II.439
2 55 \(C_{14}H_{11}O_{3}N\) 205 Its benzylamide \(C_{2}H_{5}OH\) 120.27 \(C_{6}H_{5}CH_{2}\cdot NH_{2}\) 0.041 04.II.774
3 52 \(C_{7}H_{12}O_{7}\) 210 \(\lambda\)-rhodexonic acid, \(CH_{2}\cdot(CHOH)_{4}\cdot COOH\) \(H_{2}O\) 65.52 10.I.1131
3 52 \(C_{7}H_{12}O_{6}\) 192 Its lactone \(H_{2}O\) 66.83 \(H_{2}O\) 0.052 10.I.1132
4 121 \(C_{15}H_{20}O_{3}NCl\) 309 \(O\)-chlorocampherylamic acid, \(C_{8}H_{14}<\begin{matrix}CO \cdot NH \cdot C_{6}H_{5}Cl\\ COOH\end{matrix}\) \(C_{2}H_{5}OH\) 35.53 27.II.2057
4 121 \(C_{16}H_{19}O_{2}NCl\) 291 Its imide \(C_{2}H_{5}OH\) 41.03 \(H_{2}O\) 0.154 27.II.2057
5 55 \(C_{11}H_{14}O_{4}N_{2}\) 238 Amide of \(\beta\)-benzyl-malamic acid, \(C_{6}H_{5}\cdot CH_{2}\cdot NHOC\cdot CH_{2}\cdot CHOH\cdot CONH_{2}\) \(CH_{3}OH\) 100.91 00.III.1013
5 55 \(C_{11}H_{11}O_{3}N\) 205 Its imide \(C_{2}H_{5}OH\) 120.27 \(NH_{3}\) 0.191 04.II.774
No. Ref. no. Formula Mol. wt. Compound Solvent Value Medium Coeff. Reference
6 117 $\mathrm{C_9H_{12}O_2N}$ 171 Dinitrocampholic acid
$\mathrm{NH_2}$
$\mathrm{CH_3\!-\!C\!-\!CH\cdot COOH}$
$\qquad\mathrm{\vert\ \ \ \ \vert}$
$\qquad\mathrm{CH_2}$
$\qquad\mathrm{\vert\ \ \ \ \vert}$
$\mathrm{(CH_3)_2\cdot C\!-\!CH_2}$
91.82 00.II.1071
7 117 $\mathrm{C_9H_{14}ON}$ 153 Its anhydride n. ether 111.38 $\mathrm{H_2O}$ 0.213 12.II.1026
7 56 $\mathrm{C_5H_8O_3}$ 148 Mesaconic acid
$\mathrm{HOOC\cdot CH_2\cdot CH(OCH_3)\cdot COOH}$
$(\mathrm{CH_3})_2\mathrm{CO}$ 85.88 Soc. 67.946
7 57 $\mathrm{C_5H_8O_4}$ 130 Its anhydride 109.08 $\mathrm{H_2O}$ 0.270 10.II.1036
8 59 $\mathrm{C_9H_{10}O_6}$ 178 Dimethoxysuccinic acid $(\mathrm{CH_3})_2\mathrm{CO}$ 158.93 01.II.191
8 ” $\mathrm{C_8H_8O_5}$ 160 Its anhydride 236.4 $\mathrm{H_2O}$ 0.488 10.II.1036
9 56 $\mathrm{C_6H_{10}O_5}$ 162 Ethoxysuccinic acid $(\mathrm{CH_3})_2\mathrm{CO}$ 136.08 Abs. 8.2679
9 57 $\mathrm{C_6H_8O_4}$ 144 Its anhydride 206.78 $\mathrm{H_2O}$ 0.519 ”
10 117 $\mathrm{C_9H_{16}O_3}$ 172 Trinor-hydroxy-dihydrocampholic acid Acet. eth. 120.57 12.II.1026
10 117 $\mathrm{C_9H_{14}O_2}$ 154 Its lactone $\mathrm{C_2H_5OH}$ 187.72 $\mathrm{H_2O}$ 0.556 ”
11 60 $\mathrm{C_9H_{16}O_4N_2}$ 191 Methylamide of dimethoxysuccinic acid $\mathrm{H_2O}$ 253.26 27.II.2147
11 60 $\mathrm{C_7H_{11}O_3N}$ 173 Its methylimide $(\mathrm{CH_3})_2\mathrm{CO}$ 369.82 $\mathrm{CH_3NH_2}$ 0.565 Abs. 8.2679
12 69 $\mathrm{C_8H_{16}O_3N_2}$ 188 Glycine—isoleucine
$\mathrm{C_2H_5\cdot CH\cdot NH\ CO\cdot CH_2NH_2}$
$\mathrm{\qquad\vert}$
$\mathrm{CH_3\ \ \ COOH}$
$\mathrm{H_2O}$ 27.63 09.II.1546
12 69 $\mathrm{C_5H_8O_2N_2}$ 170 Its anhydride 41.28 $\mathrm{H_2O}$ 0.602 ”
No. p/p Series No. Formula Molecular wt. NAME. PROTOFORMULA Solvent \([M]_{D}^{20}\) Relation Cyclization coefficient Literature
13 115 \(C_{13}H_{18}O_{4}\) 296 \(z\)-truxillic acid

\(\cdots\)

\(C_{6}H_{5}\cdot \overset{\vert}{CH}\cdot CH \cdot \overset{\vert}{CH}\cdot C_{6}H_{5}\)
\(\quad\quad COOH\quad COOH\)
\(C_{2}H_{6}O\) 231.97 21.I.494
14 115 \(C_{15}H_{14}O_{3}\) 278 Its anhydride

\(\cdots\)
\((CH_{3})_{2}CO\) 405.43 \(H_{2}O\) 0.748 ” 15.I.1261
14 117 \(C_{9}H_{11}O_{2}N\) 171 Aminocamphorylic acid

\(C_{8}H_{14}\begin{matrix} COOH \\ NH_{2} \end{matrix}\)
\(H_{2}O\) 49.93
14 117 \(C_{9}H_{13}ON\) 153 Its anhydride

\(\cdots\)
” 92.56 \(H_{2}O\) 0.853 ” 23.I.674
15 76 \(C_{11}H_{19}O_{4}NS\) 207 \(N\)-methylcarbamino-thiomalic acid

\(COOH\cdot CH_{2}\cdot CH\,(S\cdot CO\cdot NH\cdot CH_{3})\)
\(\quad\quad\quad\quad COOH\)
ethyl acetate 205.5
15 373 \(C_{9}H_{13}O_{2}NS\) 189 \(N\)-methyl-diketo-thiazolidine acetic acid

\(\begin{matrix} CH_{3}\cdot N & \diagdown & CO\cdot CH\cdot CH_{2}\cdot COOH \\ & \diagdown & \\ & CO\cdot S & \end{matrix}\)
\(C_{6}H_{6}\) 393.3 \(H_{2}O\) 0.913 ”
16 373 $\mathrm{C_{10}H_{16}O_3}$ 216 Pinenolic acid $\mathrm{CH_3}$—$\mathrm{CH_2}$—$\mathrm{CH}$—$\mathrm{COOH}$ ring structure with $\mathrm{COOH}$, $\mathrm{CH_3}$, $\mathrm{C(CH_3)_2}$, and $\mathrm{O}$ as shown 41.25 01.1.313
17 373 $\mathrm{C_{10}H_{14}O_4}$ 198 Its anhydride … 89.83 $\mathrm{H_2O}$ 1 : 177 02.1.1006
17 62 $\mathrm{C_{11}H_{12}O_2}$ 224 Phenylitaconic acid, sodium salt
$\mathrm{COOH \cdot CH_2 \cdot CH(COOH) \cdot CHOH \cdot C_6H_5}$
… 61.86 „
17 62 $\mathrm{C_{11}H_{10}O_4}$ 206 Phenylparaconic acid, sodium salt
$\mathrm{C_6H_5\!-\!CH\!-\!COOH}$
$\mathrm{\ \ \ \ \ \ \ \ CH\!-\!CO\!-\!CH_2}$
$\mathrm{\ \ \ \ \ \ \ \ O\!-\!CO\!-\!CH_2}$
… 135.20 $\mathrm{H_2O}$ 1 : 185 „
18 117 $\mathrm{C_9H_{17}O_2N}$ 171 Aminohydrocampholytic acid $\mathrm{CH_2\!-\!CH_2}$ skeleton with $\mathrm{(CH_3)_2C}$, $\mathrm{CH\ COOH}$, $\mathrm{C}$, $\mathrm{CH_3}$, and $\mathrm{NH_2}$ as shown 93.53 $\mathrm{H_2O}$ 15.1.1262
18 $\mathrm{C_7H_{15}ON}$ 153 Its anhydride … 111.38 $\mathrm{H_2O}$ 1 : 190 „
No. Series No. Formula Molecular weight NAME: PROTOFORMULA Solvent $[M]^{20}_{D}$ Split-off substance Cyclization coefficient Citation
19 69 $\mathrm{C_{11}H_{14}O_3N_2}$ 222 Glycyl-phenylalanine
$\mathrm{NH_2\cdot CH_2\cdot CO\cdot NH\cdot CH(COOH)\cdot CH_2\cdot C_6H_5}$
$\mathrm{H_2O}$ 93.24 08.1.130
20 47 $\mathrm{C_6H_{12}O_7}$ 196 Mannonic acid
$\mathrm{CH_2OH(CHOH)_4COOH}$
$\mathrm{H_2O}$ 30.57 $\mathrm{H_2O}$ 1.198 24.1.2509
20 47 $\mathrm{C_6H_{10}O_6}$ 178 Its $\delta$-lactone $\mathrm{H_2O}$ 87.51 $\mathrm{H_2O}$ 1.865 08.1.237
21 121 $\mathrm{C_{20}H_{23}O_2N}$ 325 $\alpha$-naphthyl-$\alpha$-camphoramic acid
$\mathrm{C_8H_{14}<\begin{matrix}COOH\\ CONH\cdot C_{10}H_7\end{matrix}}$
$\mathrm{(CH_3)_2CO}$ 24.24 10.1.1611
21 121 $\mathrm{C_{20}H_{21}ON}$ 307 Its imide 80.86 $\mathrm{H_2O}$ 2.335 97.1.146
22 52 $\mathrm{C_6H_{12}O_7}$ 196 Gulonic acid
$\mathrm{CH_2OH(CHOH)_4COOH}$
27.0 ”
22 52 $\mathrm{C_6H_{10}O_6}$ 178 Its lactone 90.0 $\mathrm{H_2O}$ 2.666 04.1.85
23 60 $\mathrm{C_{22}H_{42}O_4N_2}$ 412 o-Toluidide of dimethylmalonic acid
$\mathrm{CH_3\cdot C_6H_4\cdot NH\cdot CO\cdot CH[(OOC\cdot CH_3)_2]}$
$\mathrm{C_2H_5N}$ 88.8
23 60 $\mathrm{C_{15}H_{15}O_6N}$ 305 Diacetyl-o-tolyl-tartarimide $\mathrm{CONH\cdot C_6H_4\cdot CH_3}$ 303.23 $\mathrm{CH_3\cdot C_6H_4NH_2}$ 2.752 23.1.1622
No. Formula Value Value Substance Medium / formula shown Value Value Date / reference
24 \(C_{21}H_{27}O_5N\) 428 373 Hydroxylavdanosine. [[structural formula diagram visible]]; \(CHCl_3\) 186.5 — 12.I.152
25 \(C_{20}H_{23}O_3N\) 428 341 Corinine. [[structural formula diagram visible]] 700.41 2.755 12.I.150
25 \(C_4H_8O_4\) 52 120 \(\alpha\)-methylpiperonic acid, K salt \(CH_2OH \cdot C(OH)(CH_3) \cdot COOK\); \(H_2O\) 6.32 — 09.II.185
25 \(C_4H_6O_3\) 52 102 \(\alpha\)-methylglycidic acid, K salt [[structural formula diagram visible]]; \(H_2O\) 24.59 2.890 —
26 \(C_9H_{10}O_4\) 54 182 Phenylglyceric acid \(C_6H_5 \cdot CHOH \cdot CHOH \cdot COOH\); \(H_2O\) 72.12 — 15.I.1374
No. p/p Series No. Formula Molecular weight NAME. PROTOFORMULA Solvent \([M]_{D}^{20}\) Description Cyclization coefficient Reference
54 \(C_{9}H_{8}O_{3}\) 164 Phenylglycidic acid, Na salt

\(C_{6}H_{5}\cdot CH\)—\(CH\cdot COONa\)
\(\quad \backslash\ /\)
\(\quad O\)
\(H_{2}O\) 295.25 \(H_{2}O\) 3.093 06.I.166
27. 55 \(C_{11}H_{13}O_{4}N\) 223 \(\beta\)-benzylamino acid

\(COOH\cdot C_{6}H_{5}OH\cdot CH_{2}\cdot CONH\cdot CH_{1}\cdot\)
\(C_{2}H_{6}O\) 29.30 00.II.101
55 \(C_{11}H_{11}O_{3}N\) 215 Benzimamide

. . . . . . . . . .
120.27 \(H_{2}O\) 3.104 04.II.774
28 69 \(C_{9}H_{16}O_{3}N_{2}\) 188 \(\alpha\)-alanine—\(d\)-valine

\(C_{2}H_{5}\cdot CHNH_{2}\cdot CO\cdot NHCH(C_{3}H_{7})\cdot COOH\)
\(H_{2}O\) 11.09 08.II.1732
69 \(C_{8}H_{14}O_{2}N_{2}\) 170 Its anhydride

\(\begin{array}{ccc} C_{3}H_{7}\cdot CH & \cdots CO \\ \vert & & \vert \\ CO & \cdots NH \\ \end{array}\quad \begin{array}{c} CH\cdot CH_{3}\\ \vert\\ NH \end{array}\)
\(C_{2}H_{4}O_{2}\) 49.31 \(H_{2}O\) 3.495 .
29 52 \(C_{6}H_{10}O_{7}\) 194 \(\beta\)-Galactometasaccharic acid

\(COOH\cdot(CHOH)_{4}\cdot COOH\)
\(H_{2}O\) 35.3 10.II.1370
52 \(C_{6}H_{8}O_{6}\) 176 Its lactone

. . . . . . . . . .
171.58 \(H_{2}O\) 3.860 .
No. Formula Substance
30 C₄H₆O₆ 59 150 Tartaric acid . . . . . . . . . . . H₂O 22.0
C₄H₄O₅ 59 132 Ethylene oxide dicarboxylic acid . . . .
COOH · CH—CH · COOH
\(\quad\backslash\ \ /\)
\(\quad O\)
H₂O 132.0 4.870 25.II.184
31 C₁₅H₂₀O₄ 135 264 Santinic acid . . . . . . . . . . .
[[unclear: structural formula]]
C₂H₆O 68.11 L.623
32 C₁₅H₁₈O₃ 135 246 Santonin . . . . . . . . . . . H₂O 428.04 5.284 L.622
C₆H₁₂O₇ 47 196 Mannonic acid CH₂OH(CHOH)₄ · COOH . . . H₂O 30.57 24.I.2509
C₆H₁₀O₆ 47 178 Its β-lactone . . . . . . . . . . . H₂O 111.85 5.509 15.I.1256
33 C₆H₁₃O₂N 65 131 Leucine (CH₃)₂ · CH · CH₂ · CH(NH₂) · COOH H₂O 13.65 08.I.1633
C₁₂H₂₂O₂N 65 226 Its anhydride (leucinimide) . . . . . . C₂H₄O₂ 96.88 7.058 06.II.1400
34 C₅H₁₀O₄N 72 105 Serine CH₂OH · CH(NH₂)COOH . . . . . . H₂O 7.00 \(2_3=-15.768\) 08.I.1633
No. Series No. Formula Mol. wt. Name, protoformula Solvent \([M]^{23}_{D}\) Split off Cyclization coefficient Citation
72 \(C_{6}H_{10}O_{4}N_{2}\) 174 Its anhydride: cyclic structure with \(CO\), \(NH\), \(CH\), \(CH_{2}OH\), and \(CONH\) groups \(H_{2}O\) 117.38 \(2H_{2}O\) 7.884 07.I.1699
35 \(C_{7}H_{14}O_{7}\) 210 \(\alpha\)-Rhamnohexonic acid, \(CH_{3}(CHOH)_{5}COOH\) 13.0 97.I.146
\(C_{7}H_{12}O_{6}\) 192 Its lactone 165.0 \(H_{2}O\) 11.692 *
36 48 \(C_{7}H_{12}O_{6}\) 180 \(\beta\)-Galactometasaccharinic acid, \(CH_{2}OH(CHOH)_{4}COONa\) (new acid) \(H_{2}O\) 7.77 10.II.1370
\(C_{7}H_{10}O_{5}\) 162 \(\beta\)-Galactometasaccharin (lactone) 101.99 \(H_{2}O\) 12.126 *
37 52 \(C_{5}H_{10}O_{6}\) 166 Ribonic acid 2.0 97.I.146
\(C_{5}H_{8}O_{5}\) 148 Its lactone 30.0 \(H_{2}O\) 14.000 *
38 55 \(C_{4}H_{6}O_{5}\) 134 Malic acid \(H_{2}O\) 12.46 98.I.196
\(C_{8}H_{10}O_{8}\) 250 Its anhydride, \(C_{2}H_{2}O_{3}(COOH)_{2}\) \(H_{2}O\) 405 \(H_{2}O\) 31.584 99.II.905
39 68 \(C_{9}H_{11}O_{3}N\) 181 Tyrosine, \(OH \cdot C_{6}H_{4} \cdot CH_{2} \cdot CH(NH_{2})COOH\) KOH 16.31 L.476
\(C_{18}H_{15}O_{4}N_{2}\) 326 Its anhydride NaOH 726.98 42.572 07.II.460
40 \(C_{4}H_{8}O_{5}\) 134 Malic acid, K salt \((CH_{3})_{2}CO\) 8.94 B.32.2858
41 62 $C_5H_{10}O_3$ 250 Its anhydride 535.0 99. II. 905
41 62 $C_6H_{10}O_8$ 210 Mannosaccharic acid
$\mathrm{COOH(CHOH)_4COOH}$
$H_2O$ 2.0 69.982 97. I. 146
41 62 $C_6H_8O_6$ 192 Its double lactone
$\mathrm{O{-}CH{-}CHOH}$
    $\vert$          $\vert$
$\mathrm{OC}$        $\mathrm{CO}$
  $\backslash$          $/$
   $\mathrm{CHOH}$
  $/$          $\backslash$
$\mathrm{OH}$          $\mathrm{O}$
$2H_2O$ 356.0 177.00 96. I. 146
42 58 $C_{10}H_{11}O_5N$ 225 Phenyltartraminic acid
$\mathrm{C_6H_5NH.OC.(CHOH)_2.COOH}$
$CH_3OH$ 258.07 18. I. 1150
42 58 $C_{10}H_9O_4N$ 207 Tituranil $H_2O$ 270 0.046 04. I. 85
43 60 $C_9H_{15}O_5N$ 253 $C_6H_4.N.OC(CHOH)_2.CO$
Monoanilide of dimethoxycitric acid
$(CH_3)_2CO$ 327.63 Abs. 8.2679
43 60 $C_{12}H_{13}O_4N$ 235 Its anilide 465.53 0.421
44 337 $C_{14}H_{22}O_4$ 254 $\beta$-Propiolactone-camphoric acid
$C_8H_{14}$
$\mathrm{C{-}CH_2{-}CHOH\cdot CH_3}$
  $/$      $\backslash$
$\mathrm{CO}$      $\mathrm{COOH}$
$C_2H_6O$ 64.26 22. I. 1186
45 337 $C_{14}H_{20}O_3$ 236 Its lactone ($\alpha$-form) $H_2O$ 298.54 2.550 22. III. 546
45 337 $C_{14}H_{20}O_4$ 254 See No. 44.
45 337 $C_{14}H_{20}O_3$ 238 Its lactone ($\beta$-form). $H_2O$ 163.5 1.182 22. III. 546

A. Coefficient positive. II. Sign changes

No. Series No. Formula Molecular weight Name. Protoformula Solvent \([M]_{D}^{20}\) Cleavage Cyclization coefficient Citation
1 185 \(C_{10}H_{17}O_{3}N\) 199 \(\alpha\)-Amino acid of cis-1-isofenchone-camphoric acid \(C_{2}H_{6}O\) 22.24 \(H_{2}O\) 0.031 13. I. 2126
1 185 \(C_{10}H_{15}O_{2}N\) 181 Its imide " 22.93 * * *
2 202 \(C_{16}H_{20}O_{3}NBr\) 354 2-Bromophenyl \(\alpha\)-camphoramidic acid
\(C_{9}H_{14}\begin{cases}COOH\\ CONH\cdot C_{6}H_{4}Br\end{cases}\)
\((CH_{3})_{2}CO\) 41.772 10. I. 1611
2 " \(C_{16}H_{18}O_{2}NBr\) 336 Its imide " 44.63 \(H_{2}O\) 0.069 *
3 134 \(C_{17}H_{14}O_{3}\) 266 \(\beta\)-(Benzoyl-\(O\)-carboxylic acid)-\(\alpha\)-hydrindone \(CHCl_{3}\) 170.24 13. II. 1051
3 112 \(C_{17}H_{12}O_{3}\) 264 1-Dihydroisocoumarin-hydrindone-2,3-styran
\(C_{6}H_{4}\begin{matrix}CH_{2} & C & CH_{2} & C_{6}H_{4}\\ & CO.O & & CO\end{matrix}\)
\(C_{6}H_{6}\) 172.39 \(H_{2}\) 0.012 15. II. 227
4 428 \(C_{21}H_{27}O_{4}N\) 357 Laudanosine
\(\begin{matrix}CH_{3} & & OCH_{3}\\ CH_{2}\;N & CH{-}CH_{2} & \\ CH_{2} & & OCH_{3}\\ CH_{3}O & & \\ CH_{3}O & & \end{matrix}\)
\(C_{21}H_{40}\) 376.34 00. II. 914
No. Formula Substance / structural formula
428 \(C_{21}H_{25}O_4N\) 355 Galupin

\(\mathrm{CH_3}\), \(\mathrm{CH_2N}\), \(\mathrm{CH_3}\), \(\mathrm{CH{-}CH_2}\); ring system with \(\mathrm{CH_3O}\), \(\mathrm{OCH_3}\), \(\mathrm{OCH_3}\) substituents
* 409.67 \(H_2\) 0.088 12.I.152
5 69 \(C_9H_{19}O_3N_2\) 202 L-leucyl-\(d\)-alanine
\(C_4H_9 \cdot CH(NH_2)CO \cdot NH \cdot CH(CH_3)COOH\)
\(CH_3OH\) 47.47 \(H_2O\) 0.128 06.II.1400 *
* \(C_9H_{16}O_3N_2\) 184 Its anhydride
\(C_4H_7 \cdot CH \cdot NH \cdot CO\)
\(CO \cdot NH \cdot CH \cdot CH_3\)
\(C_2H_4O_2\) 53.56 \(H_2O\) 0.128 *
6 52 \(C_5H_{10}O_6\) 166 \(d\)-threo-1,3,4-trihydroxyvaleric acid
(Na salt)
\(H_2O\) 44.90 \(H_2O\) 0.203 10.II.1367 *
* \(C_5H_8O_5\) 148 Its lactone 54.02 \(H_2O\) 0.203 *
7 117 \(C_9H_{16}O_5\) 172 Hydroxycincholoiponic campholactone

\(\mathrm{CH_2{-}COOH}\), \(\mathrm{CH_2}\), \(\mathrm{CH_2}\), central \(\mathrm{C}\) bearing \(\mathrm{CH_3}\), \(\mathrm{COOH}\), and \(\mathrm{C(CH_3)_2}\)
\(C_9H_{16}O\) 27.52 12.I.1004
No. Series No. Formula Molecular weight NAME. PROTOFORMULA Solvent \([M]^{20}_{D}\) Elimination Cyclization coefficient Scale
7 117 \(\mathrm{C_9H_{14}O_2}\) 154 Campholactone. Protoformula: structure with \(\mathrm{CH_2}\), \(\mathrm{CH}\), \(\mathrm{O}\), \(\mathrm{CO}\), \(\mathrm{CH_2}\), \(\mathrm{C}\), \(\mathrm{CH_3}\), and \(\mathrm{C(CH_3)_2}\) in the ring 33.11 \(\mathrm{H_2O}\) 0.214 12.1.1004
8 59 \(\mathrm{C_{18}H_{14}O_5}\) 358 Dibenzoylinic acid \(\mathrm{C_2H_6O}\) 397.02 L.500
8 ” \(\mathrm{C_{18}H_{12}O_4}\) 340 Its anhydride \((\mathrm{CH_3})_2\mathrm{CO}\) 485.99 \(\mathrm{H_2O}\) 0.224 ”
9 24 \(\mathrm{C_{17}H_{20}O_5}\) 304 1,1-Diphenyl-1-arabit \(\mathrm{H_2O}\) 260.22 12.1.127
9 ” \(\mathrm{C_{17}H_{18}O_4}\) 286 Its anhydride. Protoformula: structure with \(\mathrm{C_6H_5}\) groups and an \(\mathrm{O{-}C{-}CH_2OH}\) fragment \((\mathrm{CH_3})_2\mathrm{CO}\) 328.32 \(\mathrm{H_2O}\) 0.260 ”
10 59 \(\mathrm{C_{22}H_{18}O_5}\) 410 Dicinnamate of tartaric acid \((\mathrm{CH_3})_2\mathrm{CO}\) 852.8 17.1.13
10 ” \(\mathrm{C_{22}H_{16}O_4}\) 392 Its anhydride ” 1107.4 0.298 ”
11 118 \(\mathrm{C_{10}H_{11}O_2N}\) 199 3-Amino acid, cis-1-isofenchocamphoric acid \(\mathrm{C_2H_6O}\) 17.37 \(\mathrm{H_2O}\) 13.1.2126
11 ” \(\mathrm{C_{10}H_{15}O_2N}\) 181 Its imide ” 22.93 \(\mathrm{H_2O}\) 0.320 –
No. No. Formula Compound Solvent Value \(\alpha\) Reference
12 38 \(\mathrm{C_7H_{12}O_4}\) Dimethylglutaric acid
\(\mathrm{HOOC\cdot CH(CH_3)\cdot CH_2\cdot CH(CH_3)\cdot COOH}\)
\(\mathrm{H_2O}\) 67.04 11.I.204
* \(\mathrm{C_7H_{10}O_3}\) Its anhydride \(\mathrm{C_6H_6}\) 98.83 0.474 19.I.608
13 69 \(\mathrm{C_7H_{14}O_3N_2}\) Glycyl-\(d\)-valine \(\mathrm{H_2O}\) 34.10 08.II.1731
\(\mathrm{C_7H_{12}O_2N_2}\) Its anhydride
\(\begin{array}{c}\mathrm{i{-}C_3H_7}\\[-2pt]\mathrm{\quad CH\!-\!CO}\\[-2pt]\mathrm{NH\quad\ \ NH}\\[-2pt]\mathrm{OC\!-\!CH_2}\end{array}\)
\(\mathrm{H_2O}\) 51.01 0.495
14 121 \(\mathrm{C_{16}H_{20}O_2NCl}\) \(O\)-chlorocamphanyl acid
\(\begin{array}{c}\mathrm{CONH\cdot C_6H_4Cl}\\[-2pt]\mathrm{C_8H_{14}<}\\[-2pt]\mathrm{COOH}\end{array}\)
\(\mathrm{CH_3COOC_2H_5}\) 26.57 27.II.2057
15 * \(\mathrm{C_{16}H_{18}O_2NCl}\) Its imide 40.15 0.511
46 \(\mathrm{C_3H_5O_4K}\) K—salt of glyceric acid \(\mathrm{H_2O}\) 23.70 L.475
\(\mathrm{C_3H_3O_3K}\) K—salt of glycidic acid
\(\begin{array}{c}\mathrm{CH_2\quad CH\cdot COOK}\\[-2pt]\mathrm{\ \backslash\ \ \ /\ }\\[-2pt]\mathrm{\ \ O\ }\end{array}\)
\(\mathrm{H_2O}\) 38.05 0.605 15.I.426
No. Series No. Formula Molecular weight Name. Structural formula Solvent \([M]^{20}_{D}\) Elimination Cyclization coefficient Reference
16 24 \(\mathrm{C_{18}H_{22}O_6}\)
\(\mathrm{C_{18}H_{20}O_5}\)
334
316
1,1-Diphenyl-\(\alpha\)-dulcitol
Its anhydride
Acetone
\(\mathrm{H_2O}\)
255.17
420.91
\(\mathrm{H_2O}\) 0.649 16. II. 652
*
17 69
*
\(\mathrm{C_{12}H_{24}O_3N_2}\)
\(\mathrm{C_{12}H_{22}O_2N_2}\)
244
226
L-Leucyl-\(d\)-isoleucine
Its anhydride

\((\mathrm{CH_3})_2\cdot\mathrm{CH}\cdot\mathrm{CH_2}\cdot\mathrm{CH}\cdot\mathrm{NH}\cdot\mathrm{CO}\)
\(\mathrm{CO}-\mathrm{NH}-\mathrm{CH}\)
\(\mathrm{CH}\cdot\mathrm{C_2H_5}\)
\(\mathrm{CH_3}\)
\(\mathrm{H_2O}\)
\(\mathrm{C_2H_4O_2}\)
44.23
80.81
\(\mathrm{H_2O}\) 0.827 10. II. 1288
*
18 117
*
\(\mathrm{C_9H_{17}O_2N}\)
\(\mathrm{C_9H_{15}ON}\)
171
153
Isoaminodihydrocampholytic acid
Its anhydride

\(\mathrm{CH_2}-\mathrm{C}-\mathrm{NH}\)
\(\quad\vert\ \ \ \ \vert\)
\(\mathrm{CH_2}\ \ \ \ \ \ \mathrm{O}\)
\(\quad\vert\ \ \ \ \vert\)
\(\mathrm{CH_2}-\mathrm{CH}-\mathrm{CO}\)
\(\quad\ \ \ \ \ \vert\)
\(\quad\ \ \mathrm{C(CH_3)_2}\)
\(\quad\ \ \ \ \ \vert\)
\(\quad\ \ \mathrm{CH_3}\)
\(\mathrm{H_2O}\)
\(\mathrm{C_2H_6O}\)
56.26
113.52
\(\mathrm{H_2O}\) 1.017 14. I. 788
*
19 134 \(\mathrm{C_{17}H_{13}O_3Cl}\) 300 \(\alpha\)-Pyridone-\(\beta,\gamma\)-chloro-\(\delta\)-benzyl-\(O\)-carboxylic acid

\(\mathrm{C_6H_4}\) ring bearing \(\mathrm{COOH}\), \(\mathrm{CH_2}\), \(\mathrm{CCl}\), \(\mathrm{CO}\), \(\mathrm{O}\), and \(\mathrm{C_6H_4}\) substituents
\(\mathrm{C_2H_4O_2}\) 390.0 15. II. 227
No. Formula No. Compound Constituent / structural formula Medium Reference
112 \(C_7H_{12}O_3\) 261 Dihydroisocoumarin-3,2-spiran \(C_6H_6\) 172.39 HCl 1.262 L. 499
20 59 \(C_8H_{10}O_8\) 234 Diacetyltartaric acid \(C_2H_6O\) 55.30
” \(C_8H_6O_7\) 216 Fe anhydride \(C_6H_6\) 126.77 \(H_2O\) 1.292 ”
21 69 \(C_9H_{18}O_3N_2\) 202 \(d\)-Alanyl-\(d\)-isoleucine \(CH_3\cdot CH(NH_2)\cdot CONH\cdot CH\cdot COOH\)
\(\qquad\qquad\qquad CH\cdot C_2H_5\)
\(\qquad\qquad\qquad CH_3\)
12.32 09. II. 1547
” \(C_9H_{16}O_2N_2\) 184 Its anhydride \(\begin{matrix} & NH & \diagup & CO \\ CH_3\cdot CH & & C \\ & CONH\cdot CH\cdot CH\cdot C_2H_5 \\ & & CH_3 \end{matrix}\) 30.54 \(H_2O\) 1.478 ”
22 69 \(C_{11}H_{22}O_3N_2\) 230 \(l\)-Leucyl-\(d\)-valine \(C_4H_9\cdot CH(NH_2)\cdot CONH\cdot CH(C_3H_7)\cdot COOH\) 41.4 08. II. 1732
” \(C_{11}H_{20}O_2N_2\) 212 Its anhydride \(C_5H_{10}O_2\) 106.42 \(H_2O\) 1.575 ”
23 64 \(C_3H_7O_2N\) 89 \(d\)-Alanine \(CH_3\cdot CH(NH_2)\cdot COOH\) 9.16 \(H_2O\) 1.??? 06. I. 1002
” \(C_6H_{10}O_2N_2\) 142 Its double anhydride \(\begin{matrix} CO & - & CH\cdot CH_3 \\ \diagdown & & NH \\ HN & & \diagup \\ CH & - & CO \\ \vert \\ CH_3 \end{matrix}\) 40.89 \(2H_2O\) 1.731
\(C_3 = 3.463\)
”
No. Series No. Formula Molecular weight Name; formula Solvent \([M]^{20}_{D}\) Elimination Cyclization coefficient Reference
24 67 \(C_{14}H_{14}O_{4}N_{2}\) 258 \(\alpha\)-Naphthylureidopropionic acid

\(C_{10}H_{7}\cdot C(CH_{3})\cdot COOH\)
\(\quad\quad\quad\quad NH\cdot CO\cdot NH_{2}\)
NaOH 9.604 19. I. 83
24 371 \(C_{14}H_{12}O_{2}N_{2}\) 240 \(\alpha\)-Naphthylmethylhydantoin

\(C_{10}H_{7}\cdot C(CH_{3}){-}CO\)
\(\quad\quad\quad\ \vert\quad\quad\quad\vert\)
\(\quad\quad NH{-}CO{-}NH\)
\((CH_{3})_{2}CO\) 42.84 \(H_{2}O\) 3.371 ”
25 66 \(C_{11}H_{10}O_{4}N_{2}Na\) 274 Phenylureidomalonic acid

\(C_{6}H_{5}\cdot NH\cdot CO\cdot NH\cdot CH\cdot CH_{2}\cdot COOH\)
\(\quad\quad\quad\quad\quad\quad\quad\quad COOH\)
NaOH 15.618 03. II. 175
25 68 \(C_{11}H_{10}O_{4}N_{2}Na\) 256 Phenylhydantoin-acetic acid

\(CH_{2}\cdot COOH\)
\(\quad\vert\)
\(CH{-}CO\)
\(\quad\vert\quad\quad\vert\)
\(NH{-}CO\cdot N\cdot C_{6}H_{5}\)
· 133.24 \(H_{2}O\) 7.535 ”
26 48 \(C_{9}H_{12}O_{6}\) 180 Isocharinic acid 11.0 97. I. 146
26 ” \(C_{9}H_{10}O_{5}\) 162 \(\alpha\)-Isocharin

\(CO\)—\(\begin{matrix} CH_{2}OH & H & H & O & CH_{2}OH \\ \vert & \vert & \vert & \vert & \vert \\ OH & & H & H & \end{matrix}\)
\(H_{2}O\) 100.27 \(H_{2}O\) 8.115 10. II. 1369
No. Formula Value Substance Reagent / note Value Medium Value Reference / note
27 $\mathrm{C_6H_{12}O_6}$ 48 Saccharinic acid (Na salt) $\mathrm{H_2O}$ 10.27 $\mathrm{H_2O}$ 13.800 08.I.1766
$\mathrm{C_6H_{10}O_6}$ Sugar $\mathrm{H_2O}$ 151.98 *
28 $\mathrm{C_3H_6O_3}$ 43 Lactic acid $\mathrm{CH_3\cdot CHOH\cdot COOH}$ $\mathrm{H_2O}$ 5.274 $\mathrm{H_2O}$ L. 470
$\mathrm{C_3H_6O_3}$ Lactic acid $\mathrm{CH_3\cdot CHOH\cdot COOH}$ 139.15 $\mathrm{H_2O}$ 25.404 *
$\mathrm{C_3H_{10}O_7}$ 162 Fe double anhydride $\mathrm{C_2H_6O}$ $\mathrm{C_2H_6O}$ *
29 $\mathrm{C_7H_{14}O_3N_2}$ 67 $\alpha$-Uramidovaleric acid — $\kappa$-ta $\mathrm{NaOH}$ 2.306 $\mathrm{NaOH}$ 10.II.554
$\mathrm{i{-}C_4H_9,\ CH,\ COOH}$
$\qquad\vert$
$\qquad\mathrm{NH\cdot CO\cdot NH_2}$
$\mathrm{C_7H_{12}O_2N_2}$ 371 Isobutylhydantoin * 106.39 $\mathrm{H_2O}$ 45.136 *
$\mathrm{i{-}C_4H_9\cdot CH,\ CO}$
$\qquad\quad\diagup\ \ \ \ \backslash\mathrm{NH}$
$\qquad\mathrm{NH\cdot CO}$
30 $\mathrm{C_3H_6O_3}$ 43 Lactic acid $\mathrm{CH_3,\ CHOH\cdot COOH}$ $\mathrm{H_2O}$ 5.274 $\mathrm{H_2O}$ L. 470
$\mathrm{C_6H_8O_4}$ 144 l-Dilactide $\mathrm{C_3H_6}$ 429.1 $2\mathrm{H_2O}$ 80.405 06.I.1329

V. The coefficient is negative. The sign does not change.

No. Series No. Formula Molecular weight Name; protoformula Solvent \([M]_{D}^{20}\) Deviation Cyclization coefficient Dates
1 58 \(C_{10}H_{14}O_{3}N\) 225 Phenylitramic acid
\(C_{6}H_{5}\cdot NH\cdot OC\cdot CHOH\cdot COOH\)
\(H_{2}O\) 237.0 18.I.1150
1 „ \(C_{10}H_{10}O_{4}N\) 207 Tartranimide
… … … … … … … … …
\(H_{2}O\) 236.6 0.006 04.I.85
2 113 \(C_{10}H_{16}O_{4}\) 200 Isophenchocamphoric acid
\((CH_{3})_{2}C—CH\cdot COOH\)
\(\qquad\quad \vert\)
\(\qquad CH_{2}\)
\(\qquad\quad \vert\)
\(\qquad C\cdot (CH_{3})COOH\)
Ether and \(C_{6}H_{6}\) 25.5
29.03
08.II.1181
3 „ \(C_{10}H_{14}O_{3}\) 182 Its anhydride
… … … … … … … … …
\(C_{6}H_{6}\) 24.49 \(H_{2}O\) 0.041 13.I.2125
3 58 \(C_{10}H_{12}O_{2}N\) 210 Tartranimide
… … … … … … … … …
\(CH_{3}OH\) 321.3 \(H_{2}O\) 0.187 18.I.1150
4 „ \(C_{10}H_{9}O_{4}\) 207 Tartranic acid No. 1
\(NH_{2}\cdot OC\cdot(CHOH)_{2}\cdot CONHC_{6}H_{5}\)
\(NH_{3}\) 270.0 \(NH_{3}\) 0.190 04.I.85
4 52 \(C_{7}H_{14}O_{7}\) 210 3-Rhodeoxonic acid
\(COOH—CHOH—CHOH—CHOH—CHOH—CH_{3}\)
\(\qquad H\quad H\quad H\quad H\)
\(\qquad \vert\quad \vert\quad \vert\quad \vert\)
\(\qquad OH\quad H\quad OH\quad OH\)
\(H_{2}O\) 92.9 10.I.1131
No. Formula No. Compound Solvent Value Solvent Concentration Reference
5 $\mathrm{C_6H_{12}O_6}$ 192 Hex. lactone $\mathrm{H_2O}$ 78.0 $\mathrm{H_2O}$ 0.191 10.I.1131
5 $\mathrm{C_6H_{12}O_6}$ 192 See No. 3. — 291.9 — — —
6 $\mathrm{C_{11}H_{13}O_3N}$ 121 $n$-Butyl-$\alpha$-camphoramic acid \(\mathrm{C_8H_{14}\begin{matrix} /\,CONH\,C_4H_9 \\ \backslash\,COOH \end{matrix}}\) $(\mathrm{CH_3})_2\mathrm{CO}$ 40.29 $\mathrm{NH_3}$ 0.233 10.I.1611
7 $\mathrm{C_{14}H_{23}O_2N}$ — Its imide ” 30.33 $\mathrm{H_2O}$ 0.328 ”
7 $\mathrm{C_{10}H_{12}O_2N_2}$ 58 Oxyphenyl-glyoxalamide $\mathrm{NH_2CO(CHOH)_2CONH\,C_6H_4OH}$ $\mathrm{CH_3OH}$ 369.6 — — 18.II.1023
7 $\mathrm{C_{10}H_{10}ON}$ — Its imide ” 266.7 $\mathrm{NH_3}$ 0.385 ”
8 $\mathrm{C_3H_3O_2}$ 20 Tropinenglycol — 10.41 — — 18.II.501
8 $\mathrm{C_3H_6O}$ — Propylene oxide \(\begin{matrix}\mathrm{CH_3\!-\!CH\!-\!CH_2}\\[-2pt]\diagdown\ \ \diagup\\[-2pt]\mathrm{\ \ \ O}\end{matrix}\) — 7.36 $\mathrm{H_2O}$ 0.414 ”
9 $\mathrm{C_{10}H_{15}O_2N}$ 122 Camphernitric acid \(\mathrm{C_8H_{14}\begin{matrix} /\,COOH \\ \backslash\,CN \end{matrix}}\) — 122.17 — — L.574
9 $\mathrm{C_{10}H_{13}ON}$ — Its anhydride $\mathrm{CHCl_3}$ 85.41 $\mathrm{H_2O}$ 0.430 12.II.1453
Nos. Series No. Formula Mol. wt. NAME. PROTOFORMULA Solvent \([M]^{20}_{D}\) Deviation Cyclization coefficient Citation
10 115 \(\mathrm{C_{20}H_{32}O_7}\) 374 Digazkol—tetramethylene—carbinol—oxycarboxylic acid

\(\mathrm{CH_3O}\) … \(\mathrm{OH}\) … \(\mathrm{COOH}\) [[unclear: structural formula shown in the cell]]
\((\mathrm{CH_3})\mathrm{CO}\) 281.0 22.1.16
11 * \(\mathrm{C_{20}H_{30}O_6}\) 356 Its lactone * *
11 60 \(\mathrm{C_{18}H_{20}O_4N_2}\) 328 Dianilide of dimethoxynatric acid \((\mathrm{CH_3})_2\mathrm{CO}\) 196.0
837.71
\(\mathrm{H_2O}\) 0.433 Abs. 8.2679
11 * \(\mathrm{C_{13}H_{13}O_4N}\) 235 Its anil * 465.53 \(\mathrm{C_6H_5NH_2}\) 0.444 *
12 121 \(\mathrm{C_{10}H_{15}O_3NCl}\) 309 \(O\)-Chlorocamphoric acid

\(\mathrm{C_{10}H_{14}}\begin{matrix}\mathrm{CONH\cdot C_6H_4Cl}\\ \mathrm{COOH}\end{matrix}\)
\(\mathrm{CH_3OH}\) 57.78 27.11.2057
13 * \(\mathrm{C_{15}H_{19}O_2NCl}\) 291 Its imide * 38.23 \(\mathrm{H_2O}\) 0.511 *
13 118 \(\mathrm{C_{10}H_{14}O_4}\) 200 Phenocamphoric acid * 27.0 16.11.255
14 * \(\mathrm{C_{10}H_{14}O_3}\) 182 Its anhydride * 17.65 \(\mathrm{H_2O}\) 0.529 *
14 69 \(\mathrm{C_{25}H_{16}O_3N_2}\) 388 L. Leucine glycine \(\mathrm{H_2O}\) 161.66 Ob. 11.1399
14 * \(\mathrm{C_8H_{14}O_2N_2}\) 170 Its anhydride * 56.01 \(\mathrm{H_2O}\) 0.535 *
No. Formula Mol. wt. Substance Solvent Reference
15 52 C₆H₁₂O₇ 196 Aldonic acid CH₂OH(CHOH)₄·COOH 19.6 24.I.2509
C₆H₁₀O₆ 178 Its lactone 12.08 H₂O 0.622 11.I.206
16 121 C₁₆H₂₉O₃N 283 n-Hexyl-α-camphoramic acid (CH₃)₂CO 47.82 10.I.1611
C₁₆H₂₇O₂N 265 Its imide 28.62 0.670
17 42 C₁₄H₂₃O₄Cl 152 Chlorosuccinic acid CH₃COOC₂H₅ 80.10 I.485
C₁₄H₂₃O₃Cl 134 Its anhydride 45.24 0.770
18 121 C₁₃H₂₀O₃N 241 n-Propyl-α-camphoramic acid (CH₃)₂CO 44.45 H₂O 10.I.1611
C₁₃H₁₈O₂N 223 Its imide 24.30 H₂O 0.829
19 337 C₁₄H₂₂O₄ 254 β-Propanol-camphocarboxylic acid structural formula shown 64.20 22.I.1186
α-form 84.08
20 C₁₄H₂₀O₃ 236 Its lactone (γ-form) 44.84 H₂O 0.874 22.III.546
121 C₁₇H₂₃O₃N 289 m-Tolyl-α-camphoramic acid (CH₃)₂CO 89.59 H₂O 10.I.1611
C₁₇H₂₁O₂N 271 Its imide 47.69 H₂O 0.878
21 121 C₁₈H₂₀O₃NCl 309 3-Chlorophenyl-α-camphoramic acid 95.48 10.I.1611
C₁₇H₁₈O₂NCl 291 Its imide 47.14 H₂O 1.025
22 394 C₁₀H₁₆O₄ 194 Phenylsuccinic acid CH₃COOC₂H₅ 337.9 Soc. 109.575
C₁₀H₈O₃ 176 Its anhydride 159.8 1.114
No. Series No. Formula Molecular weight NAME. PROTOFORMULA Solvent \([M]^{20}_{D}\) Elimination Cyclization coefficient Citation
23 58 \(C_{15}H_{20}O_{4}N_{2}\) 323 Di-\(p\)-toluidide of tartaric acid \(C_{5}H_{5}N\) 790.0 \(CH_{3}\cdot C_{6}H_{4}\cdot NH_{2}\) 1.158 04.I.84
23 ” \(C_{11}H_{13}O_{3}N\) 221 \(p\)-Toluidinic acid ” 336.0 ”
24 58 \(C_{16}H_{20}O_{4}N_{2}\) 300 Dianilide of tartaric acid \(CH_{3}OH\) 600.0 \(C_{6}H_{5}NH_{2}\) 04.I.84
24 \(C_{10}H_{9}O_{4}N\) 211 Tartranil ” 270.0 \(C_{6}H_{5}NH_{2}\) 1.222 ”
25 See No. 24. \(C_{5}H_{5}N\) 740.0 \(C_{6}H_{5}NH_{2}\) 1.370 ”
26 121 \(C_{16}H_{15}O_{4}NBr\) 351 3-Bromocamphoraminic acid \((CH_{3})_{2}CO\) 270.0
117.52
\(H_{2}O\) 1.271 10.I.1611
26 ” \(C_{16}H_{14}O_{2}NBr\) 336 Its imide \(H_{2}O\) 51.71 ”
27 121 \(C_{17}H_{23}O_{3}N\) 239 \(O\)-Tolyl-\(\alpha\)-campheramic acid \((CH_{3})_{2}CO\) 97.97 \(H_{2}O\) 1.303 10.I.1611
27 ” \(C_{17}H_{21}O_{2}N\) 271 Its imide 42.54 ”
28 116 \(C_{9}H_{18}O_{2}\) 172 1,2-Dioxymethyl-2,2,3-trimethylcyclopentane \(C_{2}H_{6}O\) 110.08 \(H_{2}O\) 21.III.106
28 ” \(C_{9}H_{14}O\) 154 Its anhydride.

\(CH_{2}\!-\!CH\!-\!CH_{2}\)
\(\quad\vert\quad\quad\ \diagdown\)
\(\quad C(CH_{3})_{2}\quad O\)
\(\quad\vert\quad\quad\diagup\)
\(CH_{2}\!-\!C\!-\!CH_{2}\)
\(\quad\quad\vert\)
\(\quad\quad CH_{3}\)
\((C_{2}H_{5})_{2}O\) 41.88 1.623 ”
29 121 \(C_{15}H_{25}O_{3}N\) 269 \(n\)-Amyl-\(\alpha\)-campheramic acid \((CH_{3})_{2}CO\) 50.84 \(H_{2}O\) 10.I.1611
29 ” \(C_{15}H_{25}O_{2}N\) 251 Its imide ” 19.32 1.631 ”
No. [[unclear: column heading]] Formula Mol. wt. Substance Solvent / formula Value Medium Value Date / note
30 121 $\mathrm{C_{17}H_{23}O_3N}$ 289 $p$-Tolyl-$\beta$-campheramic acid $\mathrm{C_2H_6O}$ 184.96 09.II.2155
30 121 $\mathrm{C_{17}H_{21}O_2N}$ 271 Its imide 66.39 $\mathrm{H_2O}$ 1.786 *
31 121 $\mathrm{C_{16}H_{20}O_3NCl}$ 309 $p$-Chlorophenyl-$\alpha$-campheramic acid $\mathrm{(CH_3)_2CO}$ 118.96 27.II.2057
31 121 $\mathrm{C_{16}H_{18}O_2NCl}$ 291 Its imide 41.61 $\mathrm{H_2O}$ 1.853 *
32 121 Same $\mathrm{CH_3OH}$ 181.69 $\mathrm{H_2O}$ 2.153
33 121 Same $\mathrm{C_2H_6O}$ 57.61 $\mathrm{H_2O}$ 2.947
33 121 Same 158.51
34 121 Same $\mathrm{CH_3COC_2H_5}$ 40.15 $\mathrm{H_2O}$ 2.147
34 121 Same 151.10
35 39 $\mathrm{C_{22}H_{19}O_3N}$ 345 Mononitro-diphenylcamphoric acid $\mathrm{(CH_3)_2CO}$ 1166.79 $\mathrm{H_2O}$ 2.034 24.II.2397
35 39 $\mathrm{C_{22}H_{17}O_2N}$ 327 Its anil $\mathrm{CHCl_3}$ 384.55 ”
36 121 $\mathrm{C_{17}H_{23}O_3N}$ 289 $p$-Tolyl-$\alpha$-campheramic acid $\mathrm{(CH_3)_2CO}$ 106.93 $\mathrm{H_2O}$ 2.107 10.I.1611
36 121 $\mathrm{C_{17}H_{21}O_2N}$ 271 Its imide 34.41 $\mathrm{H_2O}$ ”
36 121 $\mathrm{C_{17}H_{23}O_3N}$ 289 Benzylcamphoramic acid
$\mathrm{C_8H_{14}}\begin{matrix}\diagup\!\mathrm{CONH\cdot CH_2C_6H_5}\\ \diagdown\!\mathrm{COOH}\end{matrix}$
$\mathrm{C_2H_6O}$ 99.88 24.II.2466
37 121 $\mathrm{C_{17}H_{20}O_2}$ 271 Campherbenzylidene 30.19 $\mathrm{H_2O}$ 2.308 ”
38 121 $\mathrm{C_{16}H_{20}O_3NCl}$ 309 $m$-Chlorophenyl-$\alpha$-campheramic acid $\mathrm{CH_3OH}$ 162.22 $\mathrm{H_2O}$ 2.937 27.II.2057
38 121 $\mathrm{C_{16}H_{18}O_2NCl}$ 291 Its imide 41.20 $\mathrm{H_2O}$
No. p/p Series No. Formula Molecular weight Name; structural formula Solvent \([M]_{D}^{20}\) Elimination Cyclization coefficient Citation
39 121 \(C_{20}H_{23}O_{3}N\) 325 \(\beta\)-Naphthyl-\(\alpha\)-campherylic acid \((CH_{3})_{2}CO\) 210.92 \(H_{2}O\) 2.816 10.I.1611
39 121 \(C_{20}H_{21}O_{2}N\) 307 Its imide same 55.26 same
40 38 \(C_{8}H_{14}O_{5}\) 218 Camphoronic acid
\((CH_{3})_{2},\ C(COOH),\ CH_{2},\ COOH\)
\(H_{2}O\) 52.12 L.574
41 same \(C_{9}H_{12}O_{4}\) 200 Anhydrocamphoronic acid \(CHCl_{3}\) 11.12 \(H_{2}O\) 3.686 Abs.24.1828
41 121 \(C_{10}H_{17}O_{3}N\) 199 \(\alpha\)-Camphoriminic acid \(C_{2}H_{6}O\) 89.55 L.574
41 121 \(C_{10}H_{15}O_{2}N\) 181 Its imide same 10.99 \(H_{2}O\) 7.148 24.II.2466
42 53 \(C_{8}H_{10}O_{7}\) 194 \(\beta\)-Dextrometasaccharonic acid (Na salt) \(H_{2}O\) 68.32 10.II.1371
42 53 \(C_{6}H_{8}O_{6}\) 176 Its lactone same 8.32 \(H_{2}O\) 7.211 same
43 121 \(C_{16}H_{21}O_{7}N\) 291 \(\alpha\)-Lyxtriyl camphoriminic acid
\(\begin{array}{c} H\quad H\quad O\quad OH \\ \vert\quad \vert\quad \vert\quad \vert \\ COOH\!-\!C\!-\!C\!-\!C\!-\!C\!-\!COOH \\ \vert\quad \vert\quad \vert\quad \vert \\ OH\quad OH\quad H\quad H \end{array}\)
\(C_{2}H_{5}O\) 134.90 10.II.1216
43 121 \(C_{15}H_{19}O_{3}\) 273 Its imide same 14.98 \(H_{2}O\) 8.000 •
44 117 \(C_{9}H_{16}O_{5}\) 172 Camphoinic acid same 114.12 14.I.788
44 117 \(C_{9}H_{14}O_{4}\) 154 Campholactone \(C_{2}H_{6}O\) 11.56 \(H_{2}O\) 8.872 12.II.1026
No. Formula Substance Solvent Reference
45 121 $\mathrm{C_{10}H_{17}O_3N}$ 199 $\beta$-Camphoramic acid 119.4 L. 574
$\mathrm{C_{10}H_{15}O_2N}$ 181 Camphorimide 10.99 $\mathrm{H_2O}$ 9.864 24. II. 2466
46 69 $\mathrm{C_5H_{10}O_3N_2}$ 146 Hippuryl-$d$-alanine 73.0 $\mathrm{H_2O}$ 07. I. 1107
$\mathrm{C_5H_8O_2N_2}$ 128 Its anhydride 6.65 $\mathrm{H_2O}$ 9.977 „
47 130 $\mathrm{C_9H_{14}O_4}$ 170 $d$-$\Delta^4$-trans-tetrahydrophthalic acid 195.84 09. II. 607
$\mathrm{C_9H_8O_3}$ 152 Its anhydride 10.03 $\mathrm{H_2O}$ 10.485 „
48 121 $\mathrm{C_{16}H_{16}O_5N_2}$ 320 $m$-Nitrophenyl-$\alpha$-camphorimide acid 102.4 $(\mathrm{CH_3})_2\mathrm{CO}$ 10. I. 1611
$\mathrm{C_{16}H_{14}O_4N_2}$ 302 Its imide 5.13 $\mathrm{H_2O}$ 18.961 „
49 60 $\mathrm{C_{12}H_{20}O_4N_2}$ 356 Diaminodiethoxysuccinic acid 936.28 $(\mathrm{CH_3})_2\mathrm{CO}$ Abs. 8. 2679
$\mathrm{C_{14}H_{17}O_4N}$ 311 Its anil 566.64 $\mathrm{C_6H_5NH_2}$ 0.395 „

V. The coefficient is negative. II. The sign changes.

No. Series No. Formula Molecular wt. Name. Protoformula Solvent \([M]^{20}_{D}\) Elimination Cyclization coefficient Reference
1 121 \(C_{13}H_{20}O_{3}NCl\) 309 \(O\)-Chlorophin-\(\alpha\)-campheramic acid \((CH_{3})_{2}CO\) 40.78 27.II.2057
1 121 \(C_{13}H_{20}O_{2}NCl\) 291 Its imide " 35.21 \(H_{2}O\) 0.158 "
2 117 \(C_{10}H_{16}O_{3}\) 184 Camphenolic acid. \(CH\cdot CH_{3}\) / \(CH\cdot COOH\) … \(C(OH)=(CH_{3})_{2}\) 328.8 99.I.983
" "
" 166 \(C_{10}H_{14}O_{2}\) 166 Carvenolide 237.8 \(H_{2}O\) 0.382 02.I.119
3 122 \(C_{10}H_{15}O_{4}Br\) 279 \(\beta\)-Bromocamphoric acid \(C_{2}H_{6}O\) 110.76 "
3 122 \(C_{10}H_{13}O_{3}Br\) 261 Its anhydride \((CH_{3})_{2}CO\) 73.08 \(H_{2}O\) 0.515 "
4 39 \(C_{16}H_{14}O_{4}\) 270 Diphenylsuccinic acid \(CH_{3}COOC_{2}H_{5}\) 1088.1 Soc. 107.444
4 39 \(C_{16}H_{12}O_{3}\) 252 Its anhydride " 663.01 \(H_{2}O\) 0.641 "
No. [[unclear: column heading]] Formula [[unclear: column heading]] Compound [[unclear: column heading]] [[unclear: column heading]] Medium [[unclear: column heading]] Reference
5 117 \(\mathrm{C_9H_{10}O_3}\) 172 cis-Camphonolic acid: \(\mathrm{CH_2{-}CHOH{-}C(CH_3)_2{-}C(CH_3){-}COOH{-}CH_2}\) \(\mathrm{C_9H_6O}\) 57.44 12.I.489
6 ” \(\mathrm{C_9H_{14}O_2}\) 154 Fe lactone ” 34.24 \(\mathrm{H_2O}\) 0.677 12.I.811
6 121 \(\mathrm{C_{10}H_{18}O_2N_2}\) 198 Dimethylcamphoric acid \(\mathrm{CHCl_3}\) 20.98 L.573
6 \(\mathrm{C_{10}H_{15}O_2N}\) 181 Fe imide \(\mathrm{C_2H_6O}\) 10.99 \(\mathrm{NH_3}\) 0.909 24.II.2466
7 \(\mathrm{C_{10}H_{22}O_4}\) 206 \(\gamma,\delta\)-Dimethoxy-\(\beta,\varepsilon\)-dimethylhexane-\(\beta,\varepsilon\)-diol \(\mathrm{CH_3OH}\) 52.53 10.II.1036
7 23 \(\mathrm{C_{10}H_{22}O_4}\) 206 \(\mathrm{OH\cdot C(CH_3)_2\cdot C(CH_3)_2\cdot OH}\)
8 365 \(\mathrm{C_{10}H_{12}O_3}\) 188 Its anhydride \(\mathrm{(CH_3)_2CO}\) 25.09 \(\mathrm{H_2O}\) 1.092 ”
8 119 \(\mathrm{C_{11}H_{19}O_4N}\) 229 Carbomethyldiaminovaleric acid: \(\mathrm{HOOC\cdot C_5H_{14}\cdot NH\cdot CH_2\cdot COOH}\) \(\mathrm{H_2O}\) 104.63 11.II.532
9 \(\mathrm{C_{11}H_{17}O_3N}\) 211 N-Anhydroxymethylaminovaleric acid: \(\mathrm{C_5H_{14}}\) ring with \(\mathrm{CO}\) and \(\mathrm{N\cdot CH_2\cdot COOH}\) ” 46.84 \(\mathrm{H_2O}\) 1.233
9 121 \(\mathrm{C_{12}H_{15}O_4N}\) 319 \(p\)-Ethoxyphenyl-\(\alpha\)-campheraminic acid 16.396 10.II.1216
9 \(\mathrm{C_{15}H_{23}O_3N}\) 301 Fe imide 39.972 \(\mathrm{H_2O}\) 1.438 ”
10 120 \(\mathrm{C_{10}H_{16}O_4}\) 200 Camphoric acid \(\mathrm{C_5H_8O}\) 94.7 L.571
10 \(\mathrm{C_{10}H_{14}O_3}\) 182 Its anhydride \(\mathrm{C_6H_6}\) 12.95 \(\mathrm{H_2O}\) 6.320 L.573

For the article by Prof. Ts. Ts. Kotyukov.

Legend

—○— monosaccharide [[unclear: handwritten descriptor]]
--○-- “ mesocyclic
--●-- “ protio-cyclic
--×-- disaccharide [[unclear: handwritten descriptor]]

Axes

Vertical axis: \(A\)

Horizontal axis: molecular rotation, \(0^\circ, 5^\circ, 10^\circ, 15^\circ, 20^\circ, 25^\circ, 50^\circ, 75^\circ, 100^\circ, 125^\circ, 150^\circ\).

Submission history

On the Influence of Cyclization on Molecular Rotation